How wild-type TP53 is inactivated in undifferentiated-type gastric carcinomas: Analyses of intratumoral heterogeneity in deletion and mutation of TP53

Pathobiology

Volumn 73, Issue 1, 2006, Pages 40-49

  Yoshimura, Akinobu ^a   Sugihara, Hiroyuki ^a   Ling, Zhi Qiang ^a   Peng, Dun Fa ^a   Mukaisho, Ken Ichi ^a   Fujiyama, Yoshihide ^a   Hattori, Takanori ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Deletion; Gastric carcinoma; Genetic lineage; Intratumoral heterogeneity; Loss of heterozygosity; Mutations; TP53

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; DNA SEQUENCE; FEMALE; GENE; GENE DELETION; GENE INACTIVATION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL; STOMACH CARCINOMA; TP53 GENE; UNDIFFERENTIATED CARCINOMA;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; STOMACH NEOPLASMS;

EID: 33745432825     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000093090     Document Type: Article

References (33)

1. Laurén P: The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
2. Carneiro F: Classification of gastric carcinomas: Curr Diagn Pathol 1997;4:51-59.
3. Japanese Research Society of Gastric Cancer: Japanese Classification of Gastric Carcinoma. Tokyo, Kanehara, 1995.
4. Endoh Y, Tamura G, Watanabe H, Ajioka Y, Motoyama T: The common 18-base pair deletion at codons 418-423 of the E-cadherin gene in differentiated-type adenocarcinomas and intramucosal precancerous lesions of the stomach with the features of gastric foveolar epithelium. J Pathol 1999;189:201-206.
5. Saito A, Shimoda T, Nakanishi Y, Ochiai A, Toda G: Histologic heterogeneity and mucin phenotypic expression in early gastric cancer. Pathol Int 2001;51:165-171.
6. Peng DF, Sugihara H, Mukaisho K, Tsubosa Y, Hattori T: Alterations of chromosomal copy number during progression of diffuse-type gastric carcinomas: metaphase- and array-based comparative genomic hybridization analyses of multiple samples from individual tumours. J Pathol 2003;201:439-450.
7. Peng DF, Sugihara H, Mukaisho K, Ling ZQ, Hattori T: Genetic lineage of poorly differentiated gastric carcinoma with a tubular component analysed by comparative genomic hybridization. J Pathol 2004;203:884-895.
8. Sugihara H, Hattori T, Imamura Y, Noriki S, Fukuda M, Katsura K, Tsuchihashi Y, Fujita S: Morphology and modes of cell proliferation in earliest signet ring cell carcinomas induced in canine stomachs by N-ethyl-N′- nitro-N-nitrosoguanidine. J Cancer Res Clin Oncol 1991;117:197-204.
9. Sugihara H, Hattori T, Fukuda M, Fujita S: Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinomas of the human stomach. Virchows Arch A 1987;411:117-127.
10. Fujimori Y, Akamatsu T, Ota H, Katsuyama T: Proliferative markers in gastric carcinoma and organoid differentiation. Hum Pathol 1995;26:725-734.
11. Watanabe H, Jass JR, Sobin LH: Histological Typing of Oesophageal and Gastric Tumours, ed 3. Berlin, Springer, 1990, pp 76-78.
12. Carneiro F, Huntsman DG, Smyrk TC, Owen DA, Seruca R, Pharoah P, Caldas C, Sobrinho-Simoes M: Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening. J Pathol 2004;203:681-687.
13. Nakamura E, Sugihara H, Bamba M, Hattori T: Dynamic alteration of the E-cadherin/catenin complex during cell differentiation and invasion of undifferentiated-type gastric carcinomas. J Pathol 2005;205:349-358.
14. Greenblatt MS, Bennett WP, Hollstein M, Harris CC: Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994;54:4855-4878.
15. Prives C, Hall PA: The p53 pathway. J Pathol 1999;187:112-126.
16. O'Farrel TJ, Ghosh P, Dobashi N, Sasaki CY, Longo DL: Comparison of the effect of mutant and wild-type p53 on global gene expression. Cancer Res 2004;64:8199-8207.
17. Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet 1999;21:163-167.
18. Oue N, Oshimo Y, Nakayama H, Ito R, Yoshida K, Matsusaki K, Yasui W: DNA methylation of multiple genes in gastric carcinoma: association with histological type and CpG island methylator phenotype. Cancer Sci 2003;94:901-905.
19. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A: TP53 and gastric carcinoma: a review. Hum Mutat 2003;21:258-270.
20. Uchino S, Noguchi M, Hirota T, Itabashi M, Saito T, Kobayashi M, Hirohashi S: High incidence of nuclear accumulation of p53 protein in gastric cancer. Jpn J Clin Oncol 1992;22:225-231.
21. Sugai T, Nakamura S, Uesugi N, Habano W, Yoshida T, Tazawa H, Orii S, Suto T, Itoh C: Role of DNA aneuploidy, overexpression of p53 gene product, and cellular proliferation in the progression of gastric cancer. Cytometry 1999;38:111-117.
22. Fiocca R, Luinetti O, Villani L, Mastracci L, Quilici P, Grillo F, Ranzani GN: Molecular mechanisms involved in the pathogenesis of gastric carcinoma: interactions between genetic alterations, cellular phenotype and cancer histotype. Hepatogastroenterology 2001;48:1523-1530.
23. Luinetti O, Fiocca R, Villani L, Alberizzi P, Ranzani GN, Solcia E: Genetic pattern, histological structure, and cellular phenotype in early and advanced gastric cancers: evidence for structure-related genetic subsets and for loss of glandular structure during progression of some tumors. Hum Pathol 1998;29:702-709.
24. Bamba M, Sugihara H, Okada K, Bamba T, Hattori T: Clonal analysis of superficial depressed-type gastric carcinoma in humans. Cancer 1998;83:867-875.
25. Lengauer C, Kinzler KW, Vogelstein B: Genetic instabilities in human cancers. Nature 1998;396:643-649.
26. Tsao JL, Tavaré S, Salovaara R, Jass JR, Aaltonen LA, Shibata D: Colorectal adenoma and cancer divergence - evidence of multilineage progression. Am J Pathol 1999;154:1815-1824.
27. Höglund M, Gisselsson D, Hansen GB, Säll T, Mitelman F: Ovarian carcinoma develops through multiple modes of chromosomal evolution. Cancer Res 2003;63:3378-3385.
28. Tokugawa T, Sugihara H, Tani T, Hattori T: Modes of silencing of p16 in development of esophageal squamous cell carcinoma. Cancer Res 2002;62:4938-4944.
29. Sekido Y, Uemura S, Takekoshi S, Suzuki Y, Tokuda Y, Tajima T, Osamura RY: Heterogeneous gene alterations in primary breast cancer contribute to discordance between primary and asynchronous metastatic/recurrent sites: Her2 gene amplification and p53 mutation. Int J Oncol 2003;22:1225-1232.
30. Sugihara H, Hattori T, Fujita S, Hirose K, Fukuda M: Regional ploidy variations in signet ring cell carcinomas of the stomach. Cancer 1990;65:122-129.
31. Noda H, Maehara Y, Irie K, Kakeji Y, Yonemura T, Sugimachi K: Growth pattern and expression of cell cycle regulator proteins p53 and p21WAF1/CIP1 in early gastric carcinoma. Cancer 2001;92:1828-1835.
32. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K: Inactivation of the 14-3-3σ gene is associated with 5′ CpG island hypermethylation in human cancers. Cancer Res 2000;60:4353-4357.
33. Nagao T, Gaffey TA, Serizawa H, Sugano I, Ishida Y, Yamazaki K, Tokashiki R, Yoshida T, Minato H, Kay PA, Lewis JE: Dedifferentiated adenoid cystic carcinoma: a clinicopathologic study of 6 cases. Mod Pathol 2003;16:1265-1272.